Vaccines more likely to get through clinical trials than other types of drugs, MIT study finds
Prof. Lo says: “...there's been only one vaccine approved. That's worrisome, because we know for a fact that these diseases are real threats.”
Prof. Lo says: “...there's been only one vaccine approved. That's worrisome, because we know for a fact that these diseases are real threats.”
“Endowments are usually thought of as rainy-day funds for NPOs to help them survive crises like the COVID-19 pandemic.” says [Prof. Andrew] Lo.
Dimitris Bertsimas said Connecticut's reopening has so far been handled “reasonably appropriately."
Ms. Cavalcanti (MBA '20) says: "I would say Sloan is a place where everyone is helpful, open, friendly, and caring."
MIT Sloan Management Review-Deloitte’s latest global executive survey and interviews are available free to the public.
Prof. Joann de Zegher is looking at whether a digital platform could be used to efficiently crowdsource market information.
“The cost of our uncoordinated national response to covid-19, it's dramatic,” said MIT economist Sinan Aral.
“I think ad-hoc interactions...are among the most important things that people miss in today's work-from-home environment.”
"Factors such as size, management, and investment allocation significantly affect how much revenue endowments generate."
3. MIT Sloan: MBA students admitted to the Sloan School of Management can apply to enter the school's Entrepreneurship & Innovation Track.